THE LIFE EXPECTANCY OF SCHIZOPHRENIC-PATIENTS WITH TARDIVE-DYSKINESIA

被引:5
作者
INADA, T [1 ]
KOSHIISHI, M [1 ]
OHNISHI, K [1 ]
YAGI, G [1 ]
机构
[1] KEIO UNIV,SCH MED,DEPT NEUROPSYCHIAT,SHINJUKU KU,TOKYO 160,JAPAN
关键词
TARDIVE DYSKINESIA; MORTALITY; LIFE EXPECTANCY; SCHIZOPHRENIA;
D O I
10.1002/hup.470070404
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Relationships between tardive dyskinesia (TD) and the life expectancy of schizophrenic patients who suffer it were examined in two studies over a 50-month period. In a prospective study, the mortality rate was found to be higher in patients with TD than in those without. This suggests either that TD is a factor tending to precipitate death, or else that it is an indication that the final period of life has been reached. The failure in the prospective study to detect medical factors which would discriminate between those TD patients who died and those who remained alive, as well as the finding of a significantly older age at death of patients with TD in the retrospective study may both support this idea. No significant differences were observed in the retrospective study in the prevalence of TD between 35 pairs of age-matched deceased and living patients. The effects of TD on life expectancy are subtle; the present results are consistent with the possibilities both that TD reduces life expectancy and that it appears at the end-stage of life.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 50 条
  • [41] BRAIN ATROPHY AND INTELLECTUAL IMPAIRMENT IN TARDIVE-DYSKINESIA
    UEYAMA, K
    FUKUZAKO, H
    TAKEUCHI, K
    HIRAKAWA, K
    FUKUZAKO, T
    HOKAZONO, Y
    TAKIGAWA, M
    MATSUMOTO, K
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1993, 47 (01): : 99 - 104
  • [42] INEFFECTIVENESS OF DEANOL IN TARDIVE-DYSKINESIA - PLACEBO CONTROLLED-STUDY
    DEMONTIGNY, C
    CHOUINARD, G
    ANNABLE, L
    PSYCHOPHARMACOLOGY, 1979, 65 (03) : 219 - 223
  • [43] THE RELATIONSHIP BETWEEN ECT RESPONSIVENESS AND SUBTYPES OF TARDIVE-DYSKINESIA IN BIPOLAR PATIENTS
    SANDYK, R
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1990, 54 (3-4) : 315 - 319
  • [44] QUANTITATIVE INSTRUMENTAL MEASUREMENT OF TARDIVE-DYSKINESIA - A REVIEW
    LOHR, JB
    CALIGIURI, MP
    NEUROPSYCHOPHARMACOLOGY, 1992, 6 (04) : 231 - 239
  • [45] Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients
    Garcia-Barceló, MM
    Lam, LCW
    Ungvari, GS
    Lam, VKL
    Tang, WK
    JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (06) : 671 - 677
  • [46] Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements
    Zhang, XY
    Zhou, DF
    Cao, LY
    Chen, DC
    Zhu, FY
    Wu, GY
    SCHIZOPHRENIA RESEARCH, 2003, 62 (03) : 245 - 250
  • [47] Serum vitamin B6 in schizophrenic and schizoaffective patients with and without tardive dyskinesia
    Miodownik, C
    Lerner, V
    Cohen, H
    Kotler, M
    CLINICAL NEUROPHARMACOLOGY, 2000, 23 (04) : 212 - 215
  • [48] Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia
    Schwartz, BL
    FayMcCarthy, M
    Kendrick, K
    Rosse, RB
    Deutsch, SI
    CLINICAL NEUROPHARMACOLOGY, 1997, 20 (04) : 364 - 370
  • [49] LOW-DOSES OF INSULIN AS A TREATMENT OF TARDIVE-DYSKINESIA - CONJUNCTURE OR CONJECTURE
    MOURET, J
    KHOMAIS, M
    LEMOINE, P
    SEBERT, P
    EUROPEAN NEUROLOGY, 1991, 31 (04) : 199 - 203
  • [50] Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia
    Yoder, KK
    Hutchins, GD
    Morris, ED
    Brashear, A
    Wang, CZ
    Shekhar, A
    SCHIZOPHRENIA RESEARCH, 2004, 71 (2-3) : 371 - 375